arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 0808.2070cond-mat.mtrl-sci
收藏

用于体内癌症治疗的碳纳米管药物递送

Drug delivery with carbon nanotubes for in vivo cancer treatment

Zhuang Liu, Kai Chen, Corrine Davis, Sarah Sherlock, Qizhen Cao, Xiaoyuan Chen, Hongjie Dai

摘要:

化学功能化的单壁碳纳米管(SWNTs)在小鼠肿瘤靶向蓄积中显示出前景,并表现出生物相容性、排泄性和低毒性。在这里,我们证明了在小鼠体内的肿瘤抑制单壁碳纳米管药物输送。将紫杉醇(PTX),一种广泛使用的癌症化疗药物,通过可裂解的酯键偶联到单壁碳纳米管上的支链聚乙二醇(PEG)链上,以获得水溶性的单壁碳纳米管-紫杉醇偶联物(SWNT-PTX)。在小鼠4 T1乳腺癌模型中,SWNT-PTX在抑制肿瘤生长方面比临床紫杉醇提供更高的功效,这是由于延长的血液循环和SWNT递送的10倍更高的肿瘤PTX摄取,这可能是通过增强的渗透性和保留(EPR)实现的。携带到网状内皮系统的药物分子从SWNTs释放并通过胆道途径排泄,对正常器官没有明显的毒性作用。因此,纳米管药物递送对于未来低药物剂量的癌症治疗具有高治疗功效和最小副作用的前景。

英文摘要:

Chemically functionalized single-walled carbon nanotubes (SWNTs) have shown promise in tumor targeted accumulation in mice and exhibit biocompatibility, excretion and little toxicity. Here, we demonstrate in-vivo SWNT drug delivery for tumor suppression in mice. We conjugate paclitaxel (PTX), a widely used cancer chemotherapy drug to branched polyethylene-glycol (PEG) chains on SWNTs via a cleavable ester bond to obtain a water soluble SWNT-paclitaxel conjugate (SWNT-PTX). SWNT-PTX affords higher efficacy in suppressing tumor growth than clinical Taxol in a murine 4T1 breast-cancer model, owing to prolonged blood circulation and 10-fold higher tumor PTX uptake by SWNT delivery likely through enhanced permeability and retention (EPR). Drug molecules carried into the reticuloendothelial system are released from SWNTs and excreted via biliary pathway without causing obvious toxic effects to normal organs. Thus, nanotube drug delivery is promising for high treatment efficacy and minimum side effects for future cancer therapy with low drug doses.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑